S&P 500 Moderna Rebound: Can Biotech Strength Cushion the AI Chip Sell-Off?

Moderna's 13% surge and a 2.5% S&P 500 Healthcare pop test whether biotech can offset an AI chip rout after SOX’s $1T wipeout. Here’s what changed.